225 related articles for article (PubMed ID: 8735280)
1. Ligand-dependent interaction of nuclear receptors with potential transcriptional intermediary factors (mediators).
Le Douarin B; vom Baur E; Zechel C; Heery D; Heine M; Vivat V; Gronemeyer H; Losson R; Chambon P
Philos Trans R Soc Lond B Biol Sci; 1996 Apr; 351(1339):569-78. PubMed ID: 8735280
[TBL] [Abstract][Full Text] [Related]
2. Differential ligand-dependent interactions between the AF-2 activating domain of nuclear receptors and the putative transcriptional intermediary factors mSUG1 and TIF1.
vom Baur E; Zechel C; Heery D; Heine MJ; Garnier JM; Vivat V; Le Douarin B; Gronemeyer H; Chambon P; Losson R
EMBO J; 1996 Jan; 15(1):110-24. PubMed ID: 8598193
[TBL] [Abstract][Full Text] [Related]
3. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors.
Le Douarin B; Nielsen AL; Garnier JM; Ichinose H; Jeanmougin F; Losson R; Chambon P
EMBO J; 1996 Dec; 15(23):6701-15. PubMed ID: 8978696
[TBL] [Abstract][Full Text] [Related]
4. The N-terminal part of TIF1, a putative mediator of the ligand-dependent activation function (AF-2) of nuclear receptors, is fused to B-raf in the oncogenic protein T18.
Le Douarin B; Zechel C; Garnier JM; Lutz Y; Tora L; Pierrat P; Heery D; Gronemeyer H; Chambon P; Losson R
EMBO J; 1995 May; 14(9):2020-33. PubMed ID: 7744009
[TBL] [Abstract][Full Text] [Related]
5. Two distinct nuclear receptor interaction domains in NSD1, a novel SET protein that exhibits characteristics of both corepressors and coactivators.
Huang N; vom Baur E; Garnier JM; Lerouge T; Vonesch JL; Lutz Y; Chambon P; Losson R
EMBO J; 1998 Jun; 17(12):3398-412. PubMed ID: 9628876
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
7. Retinoid X receptor isotype identity directs human vitamin D receptor heterodimer transactivation from the 24-hydroxylase vitamin D response elements in yeast.
Kephart DD; Walfish PG; DeLuca H; Butt TR
Mol Endocrinol; 1996 Apr; 10(4):408-19. PubMed ID: 8721985
[TBL] [Abstract][Full Text] [Related]
8. Role of the essential yeast protein PSU1 in p6anscriptional enhancement by the ligand-dependent activation function AF-2 of nuclear receptors.
Gaudon C; Chambon P; Losson R
EMBO J; 1999 Apr; 18(8):2229-40. PubMed ID: 10205176
[TBL] [Abstract][Full Text] [Related]
9. A regulatory role for RIP140 in nuclear receptor activation.
Treuter E; Albrektsen T; Johansson L; Leers J; Gustafsson JA
Mol Endocrinol; 1998 Jun; 12(6):864-81. PubMed ID: 9626662
[TBL] [Abstract][Full Text] [Related]
10. Human TAF(II)135 potentiates transcriptional activation by the AF-2s of the retinoic acid, vitamin D3, and thyroid hormone receptors in mammalian cells.
Mengus G; May M; Carré L; Chambon P; Davidson I
Genes Dev; 1997 Jun; 11(11):1381-95. PubMed ID: 9192867
[TBL] [Abstract][Full Text] [Related]
11. The interaction of the vitamin D receptor with nuclear receptor corepressors and coactivators.
Tagami T; Lutz WH; Kumar R; Jameson JL
Biochem Biophys Res Commun; 1998 Dec; 253(2):358-63. PubMed ID: 9878542
[TBL] [Abstract][Full Text] [Related]
12. Natural vitamin D3 response elements formed by inverted palindromes: polarity-directed ligand sensitivity of vitamin D3 receptor-retinoid X receptor heterodimer-mediated transactivation.
Schräder M; Nayeri S; Kahlen JP; Müller KM; Carlberg C
Mol Cell Biol; 1995 Mar; 15(3):1154-61. PubMed ID: 7862109
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone receptor does not heterodimerize with the vitamin D receptor but represses vitamin D receptor-mediated transactivation.
Raval-Pandya M; Freedman LP; Li H; Christakos S
Mol Endocrinol; 1998 Sep; 12(9):1367-79. PubMed ID: 9731705
[TBL] [Abstract][Full Text] [Related]
14. Estrogen receptor, a common interaction partner for a subset of nuclear receptors.
Lee SK; Choi HS; Song MR; Lee MO; Lee JW
Mol Endocrinol; 1998 Aug; 12(8):1184-92. PubMed ID: 9717844
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional silencing by unliganded thyroid hormone receptor beta requires a soluble corepressor that interacts with the ligand-binding domain of the receptor.
Tong GX; Jeyakumar M; Tanen MR; Bagchi MK
Mol Cell Biol; 1996 May; 16(5):1909-20. PubMed ID: 8628257
[TBL] [Abstract][Full Text] [Related]
16. Vitamin D receptor displays DNA binding and transactivation as a heterodimer with the retinoid X receptor, but not with the thyroid hormone receptor.
Thompson PD; Hsieh JC; Whitfield GK; Haussler CA; Jurutka PW; Galligan MA; Tillman JB; Spindler SR; Haussler MR
J Cell Biochem; 1999 Dec; 75(3):462-80. PubMed ID: 10536369
[TBL] [Abstract][Full Text] [Related]
17. Ligand occupancy is not required for vitamin D receptor and retinoid receptor-mediated transcriptional activation.
Matkovits T; Christakos S
Mol Endocrinol; 1995 Feb; 9(2):232-42. PubMed ID: 7776973
[TBL] [Abstract][Full Text] [Related]
18. The yeast Ada complex mediates the ligand-dependent activation function AF-2 of retinoid X and estrogen receptors.
vom Baur E; Harbers M; Um SJ; Benecke A; Chambon P; Losson R
Genes Dev; 1998 May; 12(9):1278-89. PubMed ID: 9573045
[TBL] [Abstract][Full Text] [Related]
19. Nuclear receptors modulate the interaction of Sp1 and GC-rich DNA via ternary complex formation.
Husmann M; Dragneva Y; Romahn E; Jehnichen P
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):763-72. PubMed ID: 11104684
[TBL] [Abstract][Full Text] [Related]
20. Characterization of the chimeric retinoic acid receptor RARalpha/VDR.
Pemrick SM; Abarzúa P; Kratzeisen C; Marks MS; Medin JA; Ozato K; Grippo JF
Leukemia; 1998 Apr; 12(4):554-62. PubMed ID: 9557614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
